小细胞肺癌转化到非小细胞肺癌的演变和基因型特征
Jia Zhong1, Xiaoting Li2, Zhijie Wang1
1State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021 China.
小细胞肺癌 (SCLC) 可以从非小细胞肺癌 (NSCLC) 转变,甚至在EGFR野生型患者中,揭示出不同的遗传特征. 转型SCLC患者对化疗反应良好,比典型SCLC的生存率更好.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 癌症 演化 演化 癌症 演化
背景情况:
- 小细胞肺癌 (SCLC) 转变主要观察到EGFR突变腺癌.
- SCLC转化的基因组基础在很大程度上仍然没有被描述.
- 了解SCLC转变对于开发向疗法至关重要.
研究的目的:
- 为了研究SCLC转化的进化基因组概况.
- 为了确定与SCLC转变相关的基因型特征.
- 为了比较EGFR突变体和EGFR野生型SCLC转变之间的遗传特征.
主要方法:
- 对31名SCLC转变患者的回顾性分析,最初诊断为NSCLC.
- 在12名患者的原发性和转化性病变上进行整体外体序列测试 (WES).
- 使用R软件进行临床数据分析.
主要成果:
- 在EGFR野生型患者中发生了SCLC转变,表现出独特的基因突变 (CSMD3,ADAMTS19) 和丰富的DNA损伤修复 (DDR) 签名.
- EGFR突变型转型SCLC显示了与APOBEC相关的突变模式.
- 转型SCLC的化学疗法表现出高的疾病控制率 (96.7%),中位数PFS为4.03个月,中位数OS为62.08个月.
- 克隆进化分析表明所有转变的SCLC病例都有一个共同的祖先起源.
- 转变的SCLC对免疫治疗的敏感性有限,可能是由于瘤异质性.
结论:
- 与EGFR突变病例相比,EGFR野生型患者可以经历SCLC转变,具有不同的遗传特征.
- SCLC转变与对常规化疗的良好反应和比经典SCLC更好的预后有关.
- 对转型SCLC的基因组驱动因素和治疗脆弱性的进一步研究是有必要的.
更多相关视频
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Non-LTR Retrotransposons
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
